Comparative Effects of Task-Oriented Training and Hand-Arm Bimanual Intensive in Post-Stroke Pati… (NCT07724925) | Clinical Trial Compass
RecruitingNot Applicable
Comparative Effects of Task-Oriented Training and Hand-Arm Bimanual Intensive in Post-Stroke Patients
Pakistan30 participantsStarted 2025-06-01
Plain-language summary
Stroke is a rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than a vascular origin. Among various rehabilitation strategies, Task-oriented training of low to moderate intensity and Hand-Arm bimanual intensive therapy have shown their promising results in stroke rehabilitation. So, this study aims to determine the comparative effects of Task-oriented and Hand-Arm bimanual intensive therapy on Gross and Fine motor skills of Upper Limb and Activities of Daily Living in Post-Stroke Patients.
Who can participate
Age range
45 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Age 45-70
* Gender (both male and female)
* Pre diagnosed First-time stroke patients (ischemic or hemorrhagic)
* Time since stroke: ≥3 months
* Mild to moderate upper limb impairment (ABILHAND Questionnaire: Less than 50% of items rated as "impossible.")
* Moderate functional independence in basic activities (Barthel Index score ≥ 60)
* Ability to follow commands (MMSE \> 24 or equivalent cognitive screening)
Exclusion Criteria:
* • Severe spasticity (Modified Ashworth Scale score ≥ 3) or contractures
* Other neurological conditions (Alzheimer's disease, Parkinson and dementia)
* Unstable medical conditions (diabetes and hypertension) that may interfere with participation
* Participation in any other structured upper limb rehabilitation or experimental therapy within the past 3 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.